GTCR, Surmodics argue no overlap with Biocoat despite US FTC claims
GTCR, a private equity firm, told a US federal court that it won’t control over 50 percent of the market for outsourced hydrophilic coatings after acquiring Surmodics because the latter does...To view the full article, register now.
Already a subscriber? Click here to view full article